Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
Effect of L-carnitine supplementation in comparison with moderate aerobic training on serum inflammatory parameters in healthy obese women
But Novartis doesnt want to just be a me-too. Gal likens the situation with GLP-1s to whats happening in China, where a burst of innovation has led to concerns about the real gains being made there and whether many drugs are simply offering incremental improvements over existing options, particularly in oncology
Studies so far have also focused almost exclusively on patients with type 2 diabetes, so its unclear what effect GLP-1s have on eye conditions in individuals taking them for weight loss